1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

CNSP
CNS Pharmaceuticals, Inc.US flagNASDAQ Capital Market
5.24
USD
+0.32
- -
3.01MMarket Cap

Income Statement (USD)

APIChat
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
- -
1
4
9
14
15
19
15
16
+ Selling, General & Admin
- -
1
2
4
5
6
5
6
6
+ Research & Development
- -
- -
2
5
10
9
14
9
10
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
- -
-1
-4
-9
-14
-15
-19
-15
-16
- Non-Operating (Income) Loss
- -
7
- -
- -
- -
- -
- -
- -
- -
+ Interest Expense, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
6
- -
- -
- -
- -
- -
- -
- -
Pretax Income
- -
-7
-4
-9
-14
-15
-19
-15
-16
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
- -
-7
-4
-9
-14
-15
-19
-15
-16
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
- -
-7
-4
-9
-14
-15
-19
-15
-16
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-7
-4
-9
-14
-15
-19
-15
-16
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
- -
-7
-4
-9
-14
-15
-19
-15
-16
EBIT
- -
-1
-4
-9
-14
-15
-19
-15
-16
EBITDA
- -
-1
-4
-9
-14
-15
-19
-15
-16
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
EBITA
- -
-1
-4
-9
-14
-15
-19
-15
-16
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
-434,817.59
-215,400.61
-363,764.27
-467,587.1
-288,191.21
-91,068.72
-466.89
-35.75
Basic EPS from Cont Ops
- -
-434,817.59
-215,400.61
-363,764.27
-467,587.1
-288,191.21
-91,068.72
-466.89
-35.75
Diluted Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
Diluted EPS, GAAP
- -
-434,817.59
-215,400.61
-363,764.27
-467,587.1
-288,191.21
-91,068.72
-466.89
-35.75
Diluted EPS from Cont Ops
- -
-434,817.59
-215,400.61
-363,764.27
-467,587.1
-288,191.21
-91,068.72
-466.89
-35.75

Balance Sheet (USD)

APIChat
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
- -
1
8
15
7
13
2
9
8
+ Cash, Cash Equivalents & STI
- -
- -
7
14
5
10
1
6
7
+ Cash & Cash Equivalents
- -
- -
7
14
5
10
1
6
7
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
1
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
1
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
1
1
2
3
1
1
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
- -
1
- -
- -
- -
1
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
1
- -
- -
- -
1
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
1
- -
- -
- -
1
Total Assets
- -
1
8
16
9
13
2
9
9
+ Payables & Accruals
- -
- -
- -
1
2
5
6
2
4
+ Accounts Payable
- -
- -
- -
1
2
4
- -
- -
- -
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
- -
1
- -
1
6
2
4
+ ST Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
1
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
1
- -
- -
- -
- -
- -
- -
- -
Total Current Liabilities
- -
1
- -
2
3
5
6
3
4
+ LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Liabilities
- -
1
- -
2
3
5
6
3
4
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
7
19
35
42
59
65
91
105
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
7
19
35
42
59
65
91
105
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
- -
-8
-11
-21
-35
-51
-70
-84
-100
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
- -
-1
8
14
6
8
-4
6
5
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
-1
8
14
6
8
-4
6
5
Total Liabilities & Equity
- -
1
8
16
9
13
2
9
9
Shares Outstanding
- -
- -
- -
- -
- -
- -
- -
- -
1
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Debt
- -
- -
-7
-14
-5
-10
- -
-6
-7
Net Debt to Equity
-19.27
-6.22
-95.27
-97.51
-74.91
-118.6
5.59
-99.33
-151.96
Tangible Common Equity Ratio
-36.09
-80.39
96.07
87.98
70.38
62.31
-260.58
70.99
52.44
Current Ratio
0.73
0.48
25.38
8.13
2.88
2.55
0.26
3.43
1.98
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
- -
-7
-4
-9
-14
-15
-19
-15
-16
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
7
1
1
2
2
1
1
- -
+ Stock-Based Compensation
- -
- -
- -
1
2
1
1
1
- -
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
6
- -
- -
- -
- -
- -
1
- -
+ Chg in Non-Cash Work Cap
- -
- -
- -
1
-1
3
4
-4
2
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-1
- -
-2
1
2
- -
- -
+ Inc (Dec) in Accts Payable
- -
- -
- -
1
1
2
1
-4
2
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
- -
-1
-4
-7
-14
-11
-14
-17
-14
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
10
14
5
16
2
23
14
+ Increase in Capital Stock
- -
- -
10
14
5
16
2
23
14
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
-1
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
-1
- -
- -
- -
- -
+ Other Financing Activities
- -
- -
- -
- -
1
- -
3
- -
1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
1
10
14
5
16
5
23
15
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
- -
7
7
-9
5
-10
6
1
EBITDA
- -
-1
-4
-9
-14
-15
-19
-15
-16
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
- -
-1
-4
-7
-14
-11
-14
-17
-14
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
- -
-4
-7
-14
-11
-15
-17
-14
Free Cash Flow per Basic Share
- -
-42,140.29
-198,532.89
-282,152.42
-436,905.06
-199,287.49
-68,328.17
-537.9
-31.19
Price/Free Cash Flow
- -
- -
-1.51
-0.48
-0.12
-0.03
-0.05
-0.01
-0.17
Cash Flow to Net Income
- -
0.1
0.92
0.77
0.93
0.69
0.75
1.15
0.87
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -
- -
- -